Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The FDA eliminated some paperwork physicians must complete to obtain experimental drugs for patients with life-threatening illnesses that don't respond to standard therapies.
Medical supply website AvaCare Medical provides bed-bound patients access to tens of thousands of medical supplies not always covered by insurance.
Today the Michael J. Fox Foundation for Parkinson's Research announced a data challenge to accelerate development and testing of new therapies for Parkinson's disease.
Privately held biotechnology company NGM Bio announced the start of a Phase 1 clinical trial to study an antibody that could potentially treat patients with type 2 diabetes, obesity and nonalcoholic steatohepatitis.
Women with advanced HER2-positive breast cancer respond to a less expensive experimental drug just as well as the standard drug Herceptin, according to a recent study.
Medtronic recently acquired Minneapolis-based Responsive Orthopedics, a start-up company that specializes in selling devices to hospitals involved in government cost-cutting programs.
A new report from Silicon Valley, Calif.-based Hospital Pricing Specialists shows the cost of one milligram of the common opioid overdose antidote naloxone hydrochloride is increasing at an alarming rate.
Shares of Laval, Quebec, Canada-based Valeant Pharmaceuticals International plummeted Tuesday after new CEO Joseph Papa cut 2016 earnings and sales forecasts as the company attempts to reset, according to Bloomberg.
Researchers at King's College London developed a blood test that can accurately predict whether a patient will respond to conventional antidepressants on the market.
Orthopedic implant company MẌ Orthopedics recently earned FDA approval for its dynaMẌ Nitinol Compression Screw.